Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print RSS Feed

Search Results for 'Biogen Acquires Full Tysabri Rights'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Bob Muschert, Global Sales & Business Development Director
Published February 6, 2013
Elan to receive $3.25 billion, royalties Read More »
Complying with Track and Trace
By Stephen Barlas
Published April 30, 2008
Biogen Idec blazes a path to California compliance Read More »
By Anna Shagako, Clinical Operations Head
By Business Development
By WITec GmbH
By Tom Patnaik, Director of Sales & MArketing
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On